Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Analyte Detector

By Drug Discovery Trends Editor | May 7, 2010

Available from Dorton Analytical the ultra-sensitive, universal Nano Quantity Analyte Detector (NQAD) presents a major advancement in high performance liquid chromatography detection capability.

The NQAD Nano Quantity Analyte Detector is a new and completely different kind of aerosol-based detector for HPLC.  Based on Condensation Nucleation (CNLSD) technology, the NQAD offers the ability to detect sub-nanogram levels.  Benefiting from ultra-high sensitivity the detector is ideal for searching for drug impurities, degradation products, excipients and when industrial hygiene is a concern. Both previously easy and hard-to-measure compounds can be quantified accurately with minimal sample preparation.

The NQAD detector also offers a wide dynamic range with superior linearity when compared to other aerosol-based detectors.  The detection of the NQAD detector is near universal for compounds that are less volatile than the mobile phase. Chromophores and fluorophores are not needed for detection, thereby eliminating or decreasing the need for compound derivatization. The detector is optimized for use in UHPLC, HPLC and SFC. Easy to install and operate, with one of the smallest footprints available the NQAD is ideal for use in any laboratory.

Dorton Analytical

This article was published in Drug Discovery & Development magazine: Vol. 13, No. 4, May 2010, p. 9.


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE